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Abstract 15 
Residual lactose and galactose in fermented dairy foods leads to several industrial and health concerns. 16 
There is very little information pertaining to manufacture of fermented dairy foods that are low in lactose 17 
and galactose. In the present study, comparative genomic survey demonstrated the constant presence of 18 
chromosome-encoded tagatose-6-phosphate (T6P) pathway in Lactobacillus casei group. 19 
Lactose/galactose utilization tests and β-galactosidase assay suggest that PTSGal system, PTSLac system 20 
and T6P pathway are major contributors for lactose/galactose catabolism in this group of organisms. In 21 
addition, it was found than lactose catabolism by Lb. casei group accumulated very limited galactose in 22 
the MRS-lactose medium and in reconstituted skim milk, whereas Streptococcus thermophilus and Lb. 23 
delbrueckii subsp. bulgaricus (Lb. bulgaricus) strains secreted high amount of galactose extracellularly. 24 
Moreover, co-culturing Lb. casei group with Str. thermophilus showed significant reduction in galactose 25 
content, while co-culturing Lb. casei group with Lb. bulgaricus showed significant reduction in lactose 26 
content but significant increase in galactose content in milk. Overall, the present study highlighted the 27 
potential of Lb. casei group for reducing galactose accumulation in fermented milks due to its species-28 
specific T6P pathway. 29 
Keywords: comparative genomics; galactose catabolism; tagatose-6-phosphate pathway; 30 
phosphotransferase system; Lactobacillus casei group31 
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1. Introduction 32 
Lactose containing two moieties of glucose and galactose is the principal carbohydrate in 33 
mammalian milks (Adam et al., 2004). Most of the cultured dairy foods have been manufactured with 34 
starter cultures including conventional starters and functional starters for improving the shelf life, 35 
technological and nutritional aspects of milk products (Leroy and De Vuyst, 2004). Conventional starters 36 
including Streptococcus thermophilus, Lactobacillus delbrueckii subsp. bulgaricus (Lb. bulgaricus) and 37 
Lactococcus lactis are typical dairy starters for fermenting milk due to their capabilities of fast 38 
acidification, sufficient proteolysis, texture improvement and flavor enhancement (Buckenhuskes, 1993; 39 
Leroy and De Vuyst, 2004). Research related to probiotics has accelerated the use of probiotic bacteria as 40 
functional starters for milk fermentation (Granato et al., 2010). However, investigations in cultured dairy 41 
foods and other milk products have highlighted the occurrence of lactose and galactose accumulation in 42 
these products (Alm, 1982; Portnoi and MacDonald, 2009); although consumption of these products may 43 
not result in symptoms of lactose intolerance and galactosemia, dairy products containing high level of 44 
lactose and galactose are not recommended in diets for individuals with these problems (Silanikove et al., 45 
2015; Van Calcar et al., 2014). Moreover, accumulated galactose in fermented dairy products has been 46 
associated with several industrial concerns including shoddier qualities of fermented product, browning in 47 
pizza and textural defects in cheese (Neves et al., 2010; Wu et al., 2015). Thus, efforts to remove or 48 
reduce lactose and galactose would be of health and industrial importance. Removal of lactose from milk 49 
generating lactose-free and lactose-reduced milk products could be achieved enzymatically or physically 50 
(Harju et al., 2012; Jelen and Tossavainen, 2003). Hydrolysis of lactose by lactase releases the moiety of 51 
galactose from lactose, however, this process is not able to eliminate galactose from milk and thus 52 
lactose-free milk products generated from this method is inhibited in diets of galactosemic individuals but 53 
is acceptable for lactose-intolerant people. The second method for lactose removal involves various 54 
chromatographic methods for the separation of lactose from other milk constitutes; this approach could 55 
eventually produce lactose-free and galactose-free milk products (Harju et al., 2012). However, these 56 
4 
 
commercialized lactose-free milk products by are sold in liquid form by dairy companies. Since 57 
fermented milk products have more advantages over non-fermented milk products with regards to 58 
nutritional and health-promoting benefits, it is necessary to rethink above technologies and develop new 59 
strategy to manufacture lactose-free or/and galactose-free fermented milk.  60 
Some of lactic acid bacteria (LAB) could import lactose through a permease or lactose/galactose 61 
antiporter followed by hydrolysis with cytosolic β-galactosidase into glucose and galactose; these two 62 
monosaccharides are metabolized by Embden-Meyerhof-Parnas (EMP) pathway and Leloir pathway, 63 
respectively (Devos and Vaughan, 1994). Similarly, Bifidobacterium catabolizes lactose through β-64 
galactosidase, Leloir pathway and bifid shunt after uptake via the membrane (Gonzalez-Rodriguez et al., 65 
2013). Importantly, lactose-specific or galactose-specific phosphotransferase systems (PTSLac and PTSGal) 66 
have been reported in individual strains of Lb. casei (Bettenbrock et al., 1999; Chassy and Thompson, 67 
1983a, b), Lb. rhamnosus (Tsai and Lin, 2006), Lb. gasseri (Francl et al., 2012) and Lc. lactis (Neves et 68 
al., 2010); these strains uptake lactose or galactose via membrane PTS systems resulting in the formation 69 
of lactose/galactose-6-phosphate which is further catabolized by tagatose-6-phosphate (T6P) pathway 70 
(Devos and Vaughan, 1994). Interestingly, T6P pathway does not release galactose but catabolizes 71 
galactose-6-phosphate after phosphorylation of lactose during uptake (Devos and Vaughan, 1994). This 72 
brings new insights into lactose and galactose metabolism in LAB since at least some strains having this 73 
pathway were identified and characterized; lactose-reduced and galactose-reduced fermented dairy 74 
products especially aged-cheeses could be manufactured with above unique strains. However, it is still 75 
unknown as to whether T6P pathway is strain- or species-specifically distributed in the species mentioned 76 
above, and most importantly the capacity of these T6P-positive strains for eliminating lactose and 77 
galactose. In addition, more than one species of starter culture are normally used in modern manufacture 78 
of fermented dairy products, such as Str. thermophilus and Lb. bulgaricus for yogurts, and Lc. lactis 79 
subsp. cremoris and Lc. lactis subsp. lactis for Cheddar cheese (Leroy and De Vuyst, 2004). Thus, it 80 
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would be necessary to evaluate the contents of lactose and galactose in milk when above T6P-positive 81 
Lactobacillus strains and conventional starters are both added as a co-culture. 82 
Our recent comparative survey based on Kyoto Encyclopedia of Genes and Genomes (KEGG 83 
database) conducted for all the completely sequenced strains of LAB and Bifidobacterium indicated the 84 
presence of chromosome-encoded T6P pathway in the strains of Lb. casei, Lb. rhamnosus and Lb. 85 
paracasei, whereas plasmid-encoded T6P pathway was found in some strains of Lc. lactis (Wu et al., 86 
2015). This suggests their unique capacity to catabolize lactose and galactose at the species level. Thus, in 87 
the present study, comparative genomic survey for T6P pathway identification in all the sequenced 88 
(complete, chromosome, scaffold and contig levels) strains of Lb. casei group released in GenBank 89 
database has been carried out. Further comparative characterization has been carried out to illustrate 90 
lactose and galactose catabolic capacity in Lb. casei group strains and dairy starters.  91 
2. Materials and methods 92 
2.1 Comparative genomic survey 93 
We previously observed the strain-specific characteristic of Lc. lactis subsp. cremoris that encodes 94 
T6P pathway in plasmids (Wu et al., 2015). Only a limited number of strains have been completely 95 
sequenced and their metabolic maps were constructed and released in KEGG database. To understand 96 
whether it is species-specific or strain-specific in Lb. casei group, identification of genetic elements in 97 
T6P pathway in all the sequenced strains of Lb. casei group from GenBank database was carried out by 98 
searching enzymes involved in this pathway for each genome assembly and annotation report of 187 99 
strains including 34 strains of Lb. casei, 98 strains of Lb. rhamnosus, 53 strains of Lb. paracasei and 2 100 
strains of Lb. zeae dated 25 June 2016. These strains included in the survey have varying origins.  101 
2.2 Genomic islands analysis 102 
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The position of lac-gal cluster in the chromosomes of completely sequenced representative strains 103 
of Lb. casei group was identified prior to genomic island analysis in IslandView3 integrating three 104 
different genomic island prediction methods including IslandPick, IslandPath-DIMOB and SIGI-HMM 105 
(Dhillon et al., 2015). This analysis is able to differentiate the horizontal origins in their chromosomes.  106 
2.3 Bacterial strains and cultivation conditions 107 
Bacterial strains used in this study are listed in Table 1. Lactobacillus strains were cultivated in 108 
lactobacilli MRS medium (BD Company, Franklin Lakes, NJ, USA) containing glucose as the carbon 109 
source, while strains of S. thermophilus were inoculated in M17 medium containing lactose as the carbon 110 
source. 111 
2.4 Phenol-red carbohydrate utilization assay 112 
A phenol-red carbohydrate broth (pH 7.4) consisted of 10 g/L of proteose peptone, 5 g/L of sodium 113 
chloride, 1 g/L of beef extract, 0.018 g/L of phenol red and 10 g/L of lactose or galactose was used to test 114 
the utilization ability of lactose and galactose by selected LAB strains with an inoculation size of 1% 115 
(v/v). Fresh cultures of selected LAB strains (18 h) were used to inoculate into the phenol-red 116 
carbohydrate broth. The changes in color of the broth were monitored for 24 h at 37℃. A yellow color 117 
indicated a positive fermentation, whereas a reddish color indicated a negative utilization of carbohydrate.  118 
2.5 Bacterial growth in modified MRS broth containing glucose, lactose or galactose 119 
MRS broth is an ideal medium for growing LAB due to rich nutrients. In this study, substitution of 120 
glucose with lactose or galactose in MRS broth was carried out to prepare MRS-lactose and MRS-121 
galactose broth, which was used to test the ability of lactose and galactose utilization, respectively, by the 122 
selected Lb. casei group strains. MRS-glucose was used as the control fermentation. The recipe of the 123 
modified MRS is as follows: 10 g BactoTM peptone, 10 g beef extract, 5 g yeast extract, 1 g Tween-80, 20 124 
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g α-D-glucose (for MRS-glucose broth) or 20 g β-D-galactose-(1→4)-α-D-glucose (for MRS-lactose 125 
broth) or 10 g β-D-galactose (for MRS-galactose broth), 2 g trisodium citrate dihydrate, 5 g sodium 126 
acetate trihydrate, 0.1 g magnesium sulfate heptahydrate, 0.05 g manganese sulphate monohydrate, 2 g 127 
potassium monohydrogen phosphate and 1 L of distilled water. The pH of the three broth media was 128 
adjusted to 6.5 with 2 M hydrogen chloride and autoclaved at 121℃ for 15 min. 129 
All the selected Lb. casei group strains and other LAB strains (Table 1) were firstly activated in 130 
MRS-glucose broth three times at 37℃ for 18 h before inoculating (2%; v/v) the cultures to the MRS-no 131 
sugar, MRS-glucose, MRS-galactose and MRS-lactose broths indivivisually. Optical density at the 132 
absorbance of 600 nm was used to assess the growth of each bacterial strain cultivated in MRS-no sugar, 133 
MRS-glucose, MRS-galactose and MRS-lactose broth as previously described (Wu et al., 2016). Briefly, 134 
a volume of 200 µL of each broth after inoculated with each culture was loaded into triplicate wells of 96-135 
well microplates, followed by addition of 50 µL of sterile mineral oil to cover the surface of the broth. 136 
Bacterial growth was monitored in Multiskan™ GO microplate spectrophotometer (Thermo Scientific) at 137 
37℃ within 24 h. For sugar catabolic capacity tests, long-term (72-h) cultivation was carried out to 138 
minimize the effect of inoculation size of different strains on their sugar utilization, and the volume of for 139 
incubation in each broth was 10 mL in 14-mL tube. 140 
2.6 Reconstituted skim milk fermentation 141 
Skimmed milk powder was reconstituted with distilled water and was sterilized at 121℃ for 15 min 142 
to kill all the bacteria including thermophiles and spore-forming Bacillus generally found in the milk 143 
powder. Bacterial strains were cultivated in MRS-glucose medium at 37℃ for 18 h three times prior to 144 
inoculation into the 8 mL of 10% (w/v) reconstituted skim milk (RSM; Nestlé® Carnation® Skimmed 145 
Milk Powder consisting of 27 g protein and 42 g lactose per 100 g of the powder). The conditions for 146 
milk fermentation were at 37℃ for 72 h without shaking. Independent experiments were performed in 147 
triplicates, and samples were collected for analysis after fermentation. 148 
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2.7 Determination of sugars and acids  149 
For the culture broths, MRS-lactose and MRS-galactose, centrifugation was carried out at 12,000 × 150 
g and 4℃ for 10 min to obtain the cell-free supernatants; which were 10-fold diluted for HPLC analysis. 151 
For the fermented milk, 1 g of fermented milk was diluted in 9 mL of distilled water and further 152 
centrifuged at 5,000 ×g and 4℃ for 30 min to obtain the supernatants and 20 µL of 20% (w/w) acetic acid 153 
was added to the diluted suspension if the milk was not coagulated with or that without bacterial 154 
fermentation. All the clear supernatants containing sugars and acids were filtered through 0.20 µm filter 155 
membrane.  156 
Supernatants containing lactic and acetic acids were separated and quantified using HPLC (Model 157 
Shimadzu LC-2010A, Shimadzu Corporation, Kyoto, Japan) equipped with Aminex HPX-87H HPLC 158 
column (Bio-Rad) as previously described (Wu et al., 2016).  159 
Reducing sugars including lactose, glucose and galactose in the diluted samples were first 160 
derivatized with 1-phenyl-3-methyl-5-pyrazolone (PMP) as previously described (Li and Shah, 2016). 161 
Briefly, 200 µL of sample was mixed with 200 µL of 0.6 M sodium hydroxide, followed by the addition 162 
of 400 µL of 0.5 M PMP-methanol solution, and was vortexed thoroughly for 5 seconds. The mixture was 163 
then kept in an oven at 70℃ for 90 min. After incubation, the mixture was placed in ice for 5 min and 400 164 
µL of 0.3 M hydrogen chloride was added to neutralize the mixture. Chloroform (400 µL) was used to 165 
extract residual PMP from the mixture and this process was repeated four times. The PMP-sugar 166 
derivatives in the aqueous layer were passed through a 0.20 µm filter membrane, and were further 167 
separated and quantified by HPLC (Model Shimadzu LC-2010A, Shimadzu Corporation, Kyoto, Japan) 168 
equipped with Kromasil 5u 100A C18 column (250 mm × 4.6 mm; Phenomenex). The PMP-sugar 169 
derivatives were eluted by a mixture of phosphate buffered saline (1X; pH 6.7) and acetonitrile in a ratio 170 
of 83:17 (v/v) at a flow rate of 1 mL/min. The column temperature was maintained at 30 ℃ and the 171 
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absorbance was set to 245 nm. Standards (lactose, galactose, glucose) prepared in the range of 100 mg/L 172 
to 4,000 mg/L were used to generate standard curves for quantitation. 173 
2.8 Measurement of β-galactosidase activity in the whole cell 174 
The β-galactosidase activity in the whole cell was measured with 2-nitrophenyl-β-D-175 
galactopyranoside (ONPG) as previously described with minor modifications (Yu and O'Sullivan, 2014). 176 
Briefly, selected bacterial strains were first activated in MRS-glucose broth, and later inoculated in MRS-177 
lactose broth at the size of 1% (v/v). Fresh bacterial cells at the log phase stage were used for this assay. 178 
An aliquot of 100 µL of fresh cultures (OD600) or medium (as blank) was added to 900 µL of Z buffer (60 179 
mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4), followed by the addition of 10 µL of 180 
chloroform and vortexed for 10 seconds. Then, 200 µL of a substrate solution (60 mM Na2HPO4, 40 mM 181 
NaH2PO4, 4 mg/mL ONPG) was added and the mixture was incubated at 30℃ in a water bath for yellow 182 
color development. The duration of reaction was determined by the OD420 value reaching in the range of 183 
0.6 to 0.9. If there was no yellow color development, the maximum incubation time was 90 min. The 184 
reaction was terminated by adding 500 µL of the stop solution (1 M Na2CO3) to the mixture. The cell 185 
debris was removed by centrifugation at 10,000 ×g and 25 for 5 min. The supernatants were collected for 186 
measurement of OD at 420 nm. The enzymatic activity (Miller units) was calculated as follows: 187 
(1000×OD420)/[OD600×volume of cultures (mL) × reaction time (min)]. 188 
2.9 Statistical analysis  189 
All presented data in the bar charts correspond to means ± standard deviation (SD). Significant 190 
difference (p ˂ 0.05 or p ˂ 0.01) among the groups was carried out by one-way analysis of variance 191 
(ANOVA) using IBM SPSS Statistics 20.0 version. 192 
3. Results 193 
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3.1 T6P pathway is an ancient, species-specific pathway in Lb. casei group 194 
The phylogenetic tree of lactic acid bacteria demonstrated a close genetic relationship among above 195 
three species which were classified into Lb. casei group (Fig. S1). We observed the constant presence of 196 
T6P pathway in all of the 187 sequenced strains of Lb. casei group of varying origin (Table 2). Based on 197 
this survey, it was generally concluded that T6P pathway is species-specific in Lb. casei group. This 198 
suggests that T6P pathway could catabolize lactose without accumulating galactose extracellularly (Fig. 199 
1). For conventional dairy starters such as Str. thermophilus and Lb. bulgaricus, lactose was hydrolyzed 200 
by their β-galactosidases while secreting a large amount of galactose released from lactose to milk 201 
medium; reducing sugars including galactose contribute to browning reaction efficiently (Dattatreya et al., 202 
2010), thus Lb. casei group has the potential to reduce galactose content in Mozzarella cheese for the 203 
manufacture of pizza without reduced browning reaction. 204 
To understand the origin of T6P pathway in this group, we identified the location of lac-gal cluster 205 
in chromosomes of completely sequenced representative strains of Lb. casei group (Fig. S2). Further 206 
horizontal origin analysis generated from IslandViewer3 indicated that lac-gal cluster was not close to 207 
genomic islands in these representative strains (Fig. S3). This illustrates that T6P pathway and Leloir 208 
pathway may be of ancient origins in Lb. casei group but not through gain-of-function events such as 209 
horizontal gene transfer.  210 
3.2 Effects of lactose and galactose on the growth of Lb. casei group strains 211 
Very limited information is available in regards to the lactose utilization capacity in Lb. casei group 212 
strains compared to other LAB strains. A number of 12 strains of Lb. casei group of varying origins and 9 213 
strains of other LAB strains of dairy origin were included in this study (Table 1). Phenol-red lactose and 214 
galactose utilization tests were carried out prior to fermentation studies. It is clear that the truncation of 215 
lacG in lac-gal cluster in Lb. rhamnosus GG leads to the failure of its lactose catabolism (Fig. S2 and 216 
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Table 1). Three strains (GG, WQ2 and W14) of Lb. casei group were identified as lactose-utilization-217 
negative strains (Table 1). However, these strains could ferment galactose indicating their T6P pathway 218 
(lacA, lacB, lacC and lacD) is functional or at least not deficient. Thus, the failure of lactose utilization in 219 
strains WQ2 and W14 may be due to the truncation of lacG or deficient in function of PTSLac (lacE and 220 
lacF).  221 
Bacterial growth of 22 strains inoculated in MRS broth supplemented with individual sugar 222 
including lactose, galactose and glucose is indicated in Fig. S4. A shown in this figure, Str. thermophilus 223 
and Lb. bulgaricus strains were not able to survive in the MRS medium where galactose was the sole 224 
carbon source. Notably, Lb. acidophilus group strains (511, 953 and 2413) could utilize galactose 225 
suggesting their unique galactose permease and Leloir pathway that were different than that of Str. 226 
thermophilus and Lb. bulgaricus (Fig. S4). Since three strains (GG, WQ2 and W14) of Lb. casei group 227 
were negative for phenol-red lactose utilization test (Table 1), it was also observed that their growth in 228 
MRS-lactose broth was limited compared to that in MRS-no sugar broth. However, most of selected 229 
lactose-utilization-positive strains of Lb. casei group had very similar curves of bacterial growth in MRS-230 
lactose, MRS-galactose and MRS-glucose broths (Fig. S4). In general, it is observed that the optical 231 
density for Lb. casei group strains was higher than those of other selected strains grown in MRS-glucose 232 
broth. Even in the MRS-no sugar broth, Lb. casei group strains could still replicate themselves (Fig. S4); 233 
this may be due to their unique metabolisms of nitrogen such as catabolizable amino acids (Sezonov et al., 234 
2007). 235 
3.3 Lb. casei group catabolize lactose with less galactose accumulation 236 
As shown in Fig. 2A, lactose-utilization-positive Lb. casei group strains could produce high amount 237 
of lactic acid, which is significantly (p < 0.05) higher than those from other 9 LAB strains grown in MRS-238 
lactose broth. The production of acetic acid from heterofermentative Lb. casei group strains was very 239 
limited (Fig. 2B). This suggests that the activity of pentose phosphate pathway was low in these strains 240 
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whereas most of substrate – glucose-6-phosphate was metabolized via EMP pathway (Fig. 1C). 241 
Importantly, it was observed that dairy starter strains utilized less lactose but accumulated more galactose 242 
than that of Lb. casei group strains (Fig. 2C-D). It was noted that Lb. acidophilus group strains also 243 
accumulated less galactose than Str. thermophilus and Lb. bulgaricus strains (Fig. 2D). Moreover, there 244 
was very limited amount of galactose accumulated in the medium inoculated with Lb. casei group strains 245 
(Fig. 2D). Overall, it was demonstrated that Lb. casei group strains catabolized lactose with less galactose 246 
secretion.  247 
3.4 β-Galactosidase activity was not detected Lb. casei group strains 248 
As mentioned above, lactose-utilization-negative Lb. casei group strains (GG, WQ2 and W14) 249 
failed in lactose utilization could be due to either the truncation of lacG or deficient in function of PTSLac 250 
(lacE and lacF). The autoclave temperature for MRS-lactose medium was 121℃ which partially broke 251 
down lactose. Although the above three strains survived in the MRS-no sugar and MRS-galactose media 252 
(Fig. S4), the production of acids and reduction in galactose content by these organisms were still 253 
observed (Fig. 3). However, a significant (p < 0.05) reduction in lactose content by these strains (Fig. 3B) 254 
was still observed. To understand the reason for this reduction, β-galactosidase activities of whole cells of 255 
above strains and other selected strains were measured and the result is shown in Fig. 4. Although these 256 
strains were cultivated in MRS-lactose for cytosolic β-galactosidase induction, the β-galactosidase 257 
activities of Lb. casei group strains were not detected within 90 min in the ONPG assay (Fig. 4). This 258 
indicates that Lb. casei group may not express β-galactosidase to hydrolyze lactose, but just applied T6P 259 
pathway for lactose and galactose catabolism.  260 
3.5 Lb. casei group catabolize galactose efficiently  261 
Lb. casei group strains showed very positive indication for galactose utilization (Table 1 and Fig. 262 
S4). To understand its capacity to utilize galactose, we cultivated these strains and dairy starters in MRS-263 
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galactose broth. As shown in Fig. 5, Lb. casei group strains including lactose-utilization-positive and        264 
-negative strains could utilize almost all of the galactose in the medium after 72 hour of incubation. It is 265 
noted that Lb. acidophilus group strains also utilized certain amount of galactose (Fig. 5C). This indicates 266 
that their Leloir pathway was more active than those of Str. thermophilus and Lb. bulgaricus strains, but 267 
was still less effective than T6P pathway and Leloir pathway in Lb. casei group. In general, combination 268 
of T6P pathway and Leloir pathway in Lb. casei group was very efficient in galactose catabolism. 269 
3.6 Lactose depletion by Lb. casei group was lower than those by conventional dairy starters 270 
MRS medium is an ideal medium for culturing Lb. casei group strains. To evaluate the capacity of 271 
lactose utilization in the milk environment, these strains were inoculated in RSM and the results are 272 
shown in Fig. 6. Although a reasonable amount of lactic acid production from lactose-utilization-positive 273 
Lb. casei group strains was detected, it was observed that less lactose was utilized by these strains than 274 
those by dairy starters (Fig. 6A-B). However, very limited amount (below 250 mg per 1 kg of fermented 275 
milk) of galactose was detected in milk fermented by Lb. casei group strains, whereas high amount of 276 
galactose was accumulated in milk by dairy starter fermentations (Fig. 6C).  277 
Since Lb. casei group strains were not typical starters for milk fermentation, co-cultures of these 278 
strains with dairy starters including Str. thermophilus and Lb. bulgaricus was carried out for milk 279 
fermentation. Co-culturing increased lactic acid production significantly (p < 0.01) from these organisms 280 
compared to the fermentation using mono-culture of Str. thermophilus ASCC 1275 or Lb. bulgaricus 281 
ASCC 756 alone (Fig. 6D).  Importantly, co-culturing of Str. thermophilus ASCC 1275 with Lb. casei 282 
group (strains 290 or Shirota) reduced galactose content significantly (p < 0.01) compared to the 283 
fermentation by the former strain alone, while lactose content was not significantly changed between 284 
mono-culturing and co-culturing (Fig. 6E). However, co-culturing of Lb. bulgaricus ASCC 756 with Lb. 285 
casei group (strains 290 or Shirota) reduced lactose content significantly (p < 0.01) compared to the 286 
fermentation by the former strain alone, while galactose content was also significantly (p < 0.01) changed 287 
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after co-culturing (Fig. 6F). Thus, it appears that the interactions between dairy starters and Lb. casei 288 
group strains vary from case to case. 289 
The behavior of lactose-utilization-negative strains of Lb. casei group in milk is associated with 290 
their Leloir pathway. Lactic acid production and galactose reduction were still observed in these 291 
organisms (Fig. 6G-H); this suggests that their T6P pathway was responsible for galactose reduction in 292 
milk. 293 
4. Discussion 294 
Residual lactose and galactose in fermented milk products can lead to several concerns in the 295 
quality of dairy foods and health risk (Wu et al., 2015). The present study aimed to evaluate the efficiency 296 
of conventional dairy starters and other novel LAB strains for lactose and galactose reduction. Firstly, we 297 
found the species-specific presence of T6P pathway in Lb. casei group (Table 2). There have been several 298 
reports on the identification or characterization of T6P pathway and lactose- or galactose-specific PTS 299 
systems in individual LAB strains (Bettenbrock et al., 1999; Chassy and Thompson, 1983a, b; Francl et 300 
al., 2012; Tsai and Lin, 2006). To our knowledge, this is the first global review on the identification of 301 
T6P pathway in all the sequenced strains of Lb. casei group offering novel insights for lactose and 302 
galactose catabolism in LAB at the species level (Fig. 1).  303 
Prior to the catabolism of lactose and galactose by T6P pathway, uptake of lactose and galactose 304 
through PTS systems is the first step. Although transport assay and isotopic labeling-assisted metabolite 305 
analysis have identified the presence of two specific PTSGal and PTSLac systems in Lb. casei group 306 
(Bettenbrock et al., 1999; Chassy and Thompson, 1983a), genetic elements encoding a PTSGal system 307 
have never been identified among this group. In addition, genes encoding lacZ and lactose permease or 308 
lactose/galactose antiporter have also not been identified in the genome of this group strains (data not 309 
shown). In a previous report, β-galactosidase activity in Lb. rhamnosus TCELL-1 was detected by 310 
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growing it in medium agar plate spreading 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside (X-Gal) on 311 
its surface though the data or photo was not shown (Tsai and Lin, 2006). This method generated blue 312 
colonies if the bacteria exhibited β-galactosidase (β-gal) activity after incubation for at least 12 hours. 313 
However, our ONPG assay, a standard method for measuring β-gal activity of whole bacterial cell, failed 314 
to detect the β-gal activity of Lb. casei group strains within 90 min, though these organisms were pre-315 
incubated in MRS-lactose broth. This suggests that β-gal activity of Lb. casei group was very limited; this 316 
could be evidenced by the fact that lacG-deficient Lb. rhamnosus GG strain grown in MRS-lactose 317 
medium could not utilize lactose efficiently (Fig. 3B). A significant (p < 0.05) increase in the acetic acid 318 
production and a significant (p < 0.05) decrease in the lactose content indicate that there was galactose 319 
moiety after lactose hydrolysis metabolized through Leloir pathway (Fig. 3). Hence, PTSLac system and 320 
T6P pathway contributes largely to lactose catabolism in Lb. casei group.  321 
The presence of Leloir pathway in individual strains of Lb. casei group has been identified 322 
previously (Bettenbrock and Alpert, 1998; Tsai and Lin, 2006). In addition, we found that Leloir pathway 323 
is common in all the completely sequenced strains of LAB and Bifidobacterium in our previous 324 
comparative KEGG survey (Wu et al., 2015). Although gene encoding galactose permease was not 325 
identified, the uptake activity by this permease was confirmed by transport assay for ptsH mutant strain of 326 
Lb. casei 64H (Bettenbrock et al., 1999). In addition, UDP-galactose and UDP-glucose generated from 327 
Leloir pathway were largely less abundant than galactose-6-phosphate and tagatose-1,6-diP produced 328 
from T6P pathway in Lb. casei 64H as revealed by thin layer chromatography. Similarly, mutants of this 329 
organism with defects in T6P pathway contained very limited UDP-galactose and UDP-glucose 330 
intracellularly (Bettenbrock et al., 1999). This clearly confirms that T6P pathway contributes more to 331 
galactose catabolism than Leloir pathway in Lb. casei group. Moreover, our sugar analysis also suggested 332 
that Lb. casei group strains could utilize galactose efficiently (Fig. 5). Overall, T6P pathway and PTSGal 333 
system are the major contributors to efficient galactose utilization in Lb. casei group. 334 
16 
 
Compared to conventional dairy starters, Lb. casei group strains catabolize lactose and galactose 335 
with very limited galactose accumulated in the MRS-lactose medium, MRS-galactose medium and 336 
skimmed milk (Fig. 2, Fig. 5 and Fig. 6). Cheeses normally contain less lactose and galactose than those 337 
in yogurts or yogurt-like drinks because liquid whey from curds containing large amount of sugars is 338 
drained off; further long-term ripening of cheeses allow bacterial metabolism for residual sugars (Hickey 339 
et al., 2015). Hence, Lb. casei group could be added to the curds before ripening process to manufacture 340 
galactose/lactose-low cheeses that are suitable for lactose intolerant and galactosemic people. Unlike the 341 
domesticated dairy starters, cell viability and metabolic activity of Lb. casei group cells in milk 342 
environment are the important concerns for dairy industry before adopting as dairy starter (Buckenhuskes, 343 
1993). However, it is possible to apply this group of strains as adjunct dairy starters since they have 344 
dominated and classified as non-starter LAB in cheeses (Peterson and Marshall, 1990; Settanni and 345 
Moschetti, 2010). Galactose-rich Mozzarella cheese leads to undesirable browning of the final pizza 346 
product made with such cheese after baking process (Wu et al., 2015). Our results showed that a 347 
combination of Str. thermophilus and Lb. casei group is very promising for manufacturing galactose-348 
reduced Mozzarella cheese (Fig. 6E). Notably, it appears that the interacting behavior between Str. 349 
thermophilus and Lb. casei group was different to that between Lb. bulgaricus and Lb. casei group; this is 350 
evidenced by the sugar profiles (Fig. 6E-F). Although the co-culture experiment of Lc. lactis and Lb. 351 
casei group strain was not carried out in this study, it was observed that certain strains of Lc. lactis subsp. 352 
cremoris but not Lc. lactis subsp. lactis also possesses T6P pathway for galactose reduction (Wu et al., 353 
2015). Above two subspecies of Lc. lactis are normally used as cheese starters, the T6P-positive Lc. lactis 354 
subsp. cremoris may help galactose reduction during the ripening process of cheese, i.e., aged Cheddar 355 
cheese. This type of cheese with low galactose content has been recommended for consumption by 356 
galactosemic people (Portnoi and MacDonald, 2009; Van Calcar et al., 2014). In addition, Lb. casei has 357 
been found as dominant non-starter lactobacilli in Cheddar cheese (Peterson and Marshall, 1990; Settanni 358 
and Moschetti, 2010); this suggests that cooperation between Lb. casei and Lc. lactis in milk may 359 
contribute to galactose depletion. Further understanding about these interactions between Lb. casei group 360 
17 
 
and conventional dairy starters would be necessary prior to addition of Lb. casei group to milk 361 
fermentation and cheese ripening.  362 
5. Conclusions  363 
Comparative genomic survey demonstrated species-specific characteristic of T6P pathway in Lb. 364 
casei group for lactose and galactose catabolism. Although Leloir pathway has been confirmed for 365 
galactose metabolism in this group, the undetectable β-galactosidase activity in Lb. casei group strains 366 
suggests that very limited amount of lactose could be catabolized through β-galactosidase, Leloir pathway 367 
and EMP pathway. Combining the efficient galactose utilization by this group, we conclude that T6P 368 
pathway are the major contributor for utilizing lactose and galactose by Lb. casei group after uptake by 369 
PTSLac or PTSGal system. Importantly, this group catabolizes lactose with very limited galactose secretion 370 
in MRS-lactose and RSM. Overall, Lb. casei group has the potential for reducing galactose accumulation 371 
in fermented dairy foods. 372 
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Figure legends 446 
Fig. 1. General presentation on the Leloir and tagatose-6P pathways in lactic acid bacteria. (A) The 447 
gal operon. (B) The lac operon. (C) Diagram for two pathways. Denotation: 1, glucokinase; 2, 448 
phosphoglucomutase; 3, UDP-glucose pyrophosphorylase; 4, phosphatase. It is generally regarded that 449 
lacA, lacB, lacC and lacD encodes T6P pathway whereas Leloir pathway is encoded by galM, galK, galT 450 
and galE. 451 
Fig. 2. Lactobacillus casei group strains utilize lactose with limited galactose accumulation in the 452 
MRS-lactose medium. (A) Lactic acid production. (B) Acetic acid production. (C) Residual lactose 453 
content. (D) Residual galactose content. Cultivation was carried out at 37℃ for 72 h under static 454 
condition. Denotation: ST, Str. thermophilus; LB, Lb. bulgaricus; LH, Lb. helveticus; LA, Lb. acidophilus; 455 
LC, Lb. casei; LR, Lb. rhamnosus; LP, Lb. paracasei. Lowercase letters (a, b, c & d) above the group 456 
bars is used to indicate the significance: values with no letters in common indicate a significance of p < 457 
0.05. 458 
Fig. 3. Genetically deficient Lactobacillus casei group strains was not able to utilize lactose 459 
efficiently in the MRS-lactose medium. (A) Acids production. (B) Residual lactose and galactose 460 
contents. Cultivation was carried out at 37℃ for 72 h under static condition. Denotation: LC, Lb. casei; 461 
LR, Lb. rhamnosus; LP, Lb. paracasei. *, p < 0.05; **, p < 0.01. 462 
Fig. 4. Lactobacillus casei group is deficient in β-galactosidase activity. N.D., not detectable within 90 463 
min of the assay. Denotation: ST, Str. thermophilus; LB, Lb. bulgaricus; LH, Lb. helveticus; LC, Lb. 464 
casei; LR, Lb. rhamnosus. 465 
Fig. 5. Lactobacillus casei group strains utilize galactose efficiently in the MRS-galactose medium. 466 
(A) Lactic acid production. (B) Acetic acid production. (C) Residual galactose content. Incubation was 467 
carried out at 37℃ for 72 h under static condition. N.D., not detectable (value was set to zero for group 468 
statistics). Denotation: ST, Str. thermophilus; LB, Lb. bulgaricus; LH, Lb. helveticus; LA, Lb. acidophilus; 469 
LC, Lb. casei; LR, Lb. rhamnosus; LP, Lb. paracasei. Lowercase letters (a, b, c & d) above the group 470 
bars is used to indicate the significance: values with no letters in common indicate a significance of p < 471 
0.05. 472 
Fig. 6. Lactobacillus casei group is not able to utilize more lactose than conventional dairy starters, 473 
but accumulates less galactose in milk. (A) Lactic acid production. (B) Residual lactose content. (C) 474 
Residual galactose content. (D) Lactic acid production from co-cultures. (E) Residual lactose and 475 
galactose contents from co-cultures of Str. thermophilus and Lb. casei group strains. (F) Residual lactose 476 
and galactose contents from co-cultures of Lb. bulgaricus and Lb. casei group strains. (G) Lactic acid 477 
production from lactose-utilization-negative Lb. casei group strains in milk. (H) Residual lactose and 478 
galactose contents in milk fermented by lactose-utilization-negative Lb. casei group strains. Incubation 479 
was carried out at 37℃ for 72 h under static condition. N.D., not detectable (value was set to zero for 480 
group statistics). Denotation: ST, Str. thermophilus; LB, Lb. bulgaricus; LH, Lb. helveticus; LA, Lb. 481 
acidophilus; LC, Lb. casei; LR, Lb. rhamnosus; LP, Lb. paracasei. Lowercase letters (a, b, c, d & e) 482 
above the group bars is used to indicate the significance: values with no letters in common indicate a 483 
significance of p < 0.05. N.S., not significant; **, p < 0.01. 484 
 485 
21 
 
 486 
 487 
Fig.1. Wu and Shah488 
22 
 
 489 
 490 
Fig. 2. Wu and Shah491 
23 
 
 492 
 493 
Fig. 3. Wu and Shah494 
24 
 
 495 
 496 
Fig. 4. Wu and Shah497 
25 
 
 498 
 499 
Fig. 5. Wu and Shah500 
26 
 
 501 
 502 
Fig. 6. Wu and Shah503 
27 
 
 504 
Table 1. Bacterial strains used in this study and their sugar utilization capability 505 
Classification Species Strain ID Abbreviation Source Phenol red sugar 
utilization test 
Lactose Galactose 
Conventional 
dairy 
starters 
Streptococcus 
thermophilus 
ASCC 1275 ST_1275 ASCC + - 
ASCC 1303 ST_1303 ASCC + + 
YI-B1 ST_YI-01 Laboratory stock + - 
Lactobacillus 
delbrueckii subsp. 
bulgaricus 
ASCC 756 LB_756 ASCC + - 
ASCC 859 LB_859 ASCC + - 
YI-B2 LB_YI-02 Laboratory stock + - 
Lactobacillus 
acidophilus 
group 
Lactobacillus 
helveticus 
ASCC 511  LH_511 ASCC + + 
ASCC 953 LH_953 ASCC + + 
Lactobacillus 
acidophilus 
CSCC 2413 LA_2413 CSCC + + 
Lactobacillus 
casei group 
Lactobacillus 
rhamnosus 
ASCC 1520 LR_1520 ASCC + + 
ASCC 1521 LR_1521 ASCC + + 
ASCC 2607 LR_2607 ASCC + + 
WQ2 LR_WQ2 Laboratory stock - + 
GG LR_LGG Laboratory stock - + 
Lactobacillus 
casei 
W14 LC_W14 Laboratory stock  - + 
W16 LC_W16 Laboratory stock + + 
ASCC 290 LC_290 ASCC + + 
R709 LC_R709 Laboratory stock + + 
Shirota LC_Shirota Laboratory stock  + + 
Lactobacillus 
paracasei 
ASCC 276 LP_276 ASCC + + 
ASCC 279 LP_279 ASCC + + 
Note: ASCC, Australian Starter Culture Research Center; CSCC, CSIRO Starter Culture Collection. The result of 506 
sugar utilization tests (n=3) was generated after 72 h of incubation at 37℃. +, positive fermentation (yellow); -, 507 
negative fermentation (reddish). Denotation: ST, Str. thermophilus; LB, Lb. bulgaricus; LH, Lb. helveticus; LA, Lb. 508 
acidophilus; LC, Lb. casei; LR, Lb. rhamnosus; LP, Lb. paracasei.509 
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Table 2. Distribution of T6P pathway (genes encoding lacA, lacB, lacC and lacD) in all the 510 
sequenced strains of Lb. casei group 511 
Species Sequencing 
level 
No. of 
sequenced 
strains 
T6P-positive strains 
Lb. casei Complete  8 8  
(Zhang, BL23, BD-II, LC2W, 12A, W56, LOCK919, ATCC 393) 
Chromosome 2 2  
(LcY, LcA) 
Scaffold 6 6  
(A2-362, KL1-Liu, DSM 20011, 844_LCAS, BM-LC14617, Lbs2) 
Contig 18 18 
(21/1, 32G, A2-362, CRF28, M36, T71499, UCD174, UW1, UW4, Lc-10, Lpc-37, 
UW4, 12A, 5b, N87, 867_LCAS, DPC6800, Lc1542) 
Lb. 
paracasei 
Complete  7 7  
(ATCC 334, 8700:2, N1115, JCM 8130, CAUH35, L9, KL1) 
Scaffold 6 6  
(ATCC 25302, DSM 20258, 1316.rep1_LPAR, 1316.rep2_LPAR, 275_LPAR, 
525_LPAR) 
Contig 40 40 
(Lpp230, Lpl7, Lpp122, Lpp46, Lpp226, Lpp120, Lpp223, Lpp228, Lpp221, 
Lpp49, Lpp227, CNCM I-2877, Lpp17, Lpp22, Lpp225, Lpp219, Lpp229, Lpp74, 
Lpp7, CNCM I-4270, Lpp189, Lpp14, Lpl14, Lpp37, CNCM I-4649, Lpp43, 
Lpp125, Lpp70, COM0101, DSM 20207, NRIC1981, NRIC1917, NRIC0644, 
DSM 5622, Lpp123, CNCM I-4648, Lpp48, Lpp126, Lpp71, Lpp41) 
Lb. 
rhamnosus 
Complete  7 7  
(GG, ATCC 53103, Lc 705, ATCC 8530, LOCK900, LOCK908, BPL5) 
Chromosome 1 1 
(ASCC 290) 
Scaffold 14 14 
(LMS2-1, CASL, ATCC 21052, 769_LRHA, 784_LRHA, 979_LRHA, 
944_LRHA, DSM 20021, HN001, 186_LRHA, 214_LRHA, 526_LRHA, 
390_LRHA, 541_LRHA) 
Contig 76 76 
(R0011, LRHMDP2, LRHMDP3, CRL1505, LR231, 51B, E800, PEL5, PEL6, 
K32, 24, L34, L35, L31, 116, 308, CLS17, CNCM-I-3698, Lr073, Lr071, Lr108, 
Lr138, 40f, 313, 319_LRHA, 870_LRHA, 699_LRHA, 708_LRHA, 893_LRHA, 
906_LRHA, 988_LRHA, 943_LRHA, R19-3, Lrh8, Lrh32, Lrh31, Lrh29, Lrh26, 
Lrh23, Lrh22, Lrh20, Lrh19, Lrh15, Lrh11, Lrh1, Lrh34, Lrh9, Lrh7, Lrh6, Lrh5, 
Lrh4, Lrh30, Lrh3, Lrh28, Lrh27, Lrh25, Lrh21, Lrh24, Lrh2, Lrh18, Lrh17, 
Lrh16, Lrh14, Lrh13, Lrh12, Lrh10, Lrh33, Lrh42, Lrh44, Lrh43, MTCC 5462, 
2166, Lr140, Lr053, Lr032, Lr044) 
Lb. zeae Scaffold 1 1  
(DSM 20178) 
Contig 1 1  
(KCTC 3804) 
Total strains 187 100 % presence 
Note: GenBank databased accessed in June 2016. 512 
